Siomycin A treatment in prostate cancer cell lines PC3 and LNCaP

ABSTRACT: Siomycin A treatment in prostate cancer cell lines resulted in a concurrent inhibition of specific cell cycle genes and strongly impaired cell viability.

ORGANISM(S): Homo sapiens

PROVIDER: GSE36531 | GEO | 2012/10/19

SECONDARY ACCESSION(S): PRJNA153401

REPOSITORIES: GEO